title: Why no casopitant-only arm?
authors.forename: Miriam B
authors.initials: MB
authors.lastname: Anixter
mesh_terms: D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D017294:Ondansetron / Q000627:therapeutic use; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D016896:Treatment Outcome; D014508:Urea
chemical_list: D000932:Antiemetics; D017294:Ondansetron; D010879:Piperazines; D010880:Piperidines; C531951:casopitant; D014508:Urea